Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 812 of 1,261
  1. US 8741649

    Methods for enhancing genome stability and telomere elongation in embryonic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  2. US 8740872

    Magnetically-targeted treatment for cardiac disorders

    The Board of Regents of the University of Oklahoma · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  3. US 8741866

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  4. US 8741620

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  5. US 8741316

    Highly porous, recognitive polymer systems

    The Board of Regents of the University of Texas System · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  6. US 8740615

    Implant, implant body, and abutment body

    Nanto. Precision Co., Ltd · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  7. US 8742109

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  8. US 8741315

    Methods of treating tumors in immune-privileged sites

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  9. US 8741309

    Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  10. US 8741306

    Kidney specific tumor vaccine directed against kidney tumor antigen G-250

    The Regents of the University of California · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  11. US 8741313

    Polypeptide vaccine and vaccination strategy against mycobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  12. US 8741345

    Modified release pharmaceutical compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  13. US 8741589

    Monitoring two dimensions of diabetes pathogenesis

    The Regents of the University of California · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  14. US 8742075

    Monoclonal antibodies against ANGPTL3

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  15. US 8742141

    Inhibition and treatment of prostate cancer metastasis

    Northwestern University · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  16. US 8741922

    Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  17. US 8735095

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  18. US 8735075

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted May 27, 2014 · Expires May 22, 2034

    granted
  19. US 8734830

    Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution

    KOREA UNITED PHARM. INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  20. US 8735360

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 27, 2014 · Expires May 22, 2034

    granted
  21. US 8734836

    Methods and compositions for applying pharmacologic agents to the ear

    Regents of the University of Minnesota · Granted May 27, 2014 · Expires May 22, 2034

    granted
  22. US 8734786

    Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection

    Northwestern University · Granted May 27, 2014 · Expires May 22, 2034

    granted
  23. US 8735382

    Infusion and injection solution of levodopa

    Dizlin Medical Design AB · Granted May 27, 2014 · Expires May 22, 2034

    granted
  24. US 8734778

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted May 27, 2014 · Expires May 22, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.